卖什么
向保险公司销售的临床试验匹配服务。
商业模式拆解
买家：谁掌握预算？
未核实Payers and employers (benefits/medical management), pharma sponsors' clinical teams.
触发点：什么让他们现在购买？
Compounding cancer claims costs and patients lost out of network.
工作流：什么输入变成什么输出？
Pre-screen existing patient populations, refer to open trials, then Navigation OS addresses transport, food, language and scheduling barriers through completion.
经济账：省了什么，怎么收费？
Multi-sided: sponsors pay to reach pre-qualified patients; payers/employers pay for navigation; claims a 35% reduction in patients lost to other health systems.
渠道：怎么接触到客户？
Demo-led (Schedule Demo) plus provider research network.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2025-12-02 | — | $10M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.